China’s economy expands 4.9% as positive economic signs post Covid-19 continue

Published 20-OCT-2020 10:30 A.M.

|

5 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

China’s economy continued to recover rapidly from the pandemic in Q3, expanding 4.9% year-on-year, adding to the positive signs around the world of numerous economies returning to growth rapidly.

The expansion in gross domestic product missed expectations but was still well ahead of a 3.2% increase in the second quarter, as the country’s industrial production drive helped stoke up the wider economy.

Industrial production was up 6.9% in September, with China emulating positive signs from other countries seen last week.

On Friday, the US Commerce Department reported that retail sales increased 1.9% in September versus the previous month, the fifth straight month of retail sales growth. That was more than double the rate of growth anticipated, with sales of clothing and sporting goods soaring despite the unemployment rate remaining elevated. The positive economic data came at the end of a mixed week for major US stock indices, which all finished marginally higher. Rising Covid-19 case numbers in the US and abroad are giving investors pause, with a “tug of war between rising concerns and encouraging economic data” according to analysts at financial advice firm Edward Jones.

Last week kicked off third-quarter corporate earnings season in the US, with the financials sector dipping by 0.9% after most of the big banks delivered their Q3 updates. While some banks’ profits were buoyed by spikes in trading and investment banking revenues, and loan loss provision were nowhere near as severe as last quarter, there is uncertainty about whether government stimulus has prevented heavy loan delinquencies from hitting entirely, or merely delayed the inevitable.

Pelosi sets 48-hour deadline on stimulus negotiations

The S&P 500, Dow Jones Industrial Average and Nasdaq Composite all made it through the first week of Q3 corporate earnings relatively unscathed, despite an expected 20% decline in S&P 500 company earnings year-over-year (according to FactSet). US Covid-19 cases also surged back to the 60,000-a-day mark, heading back towards July’s peak levels after dropping below 35,000 in mid-September.

Notable over the weekend was a 48-hour deadline set by House Speaker Nancy Pelosi for an agreement on a new stimulus package to be agreed in order for it to be passed before the November 3 presidential election. There remains a substantial gap between Democrat and Republican lawmakers on the contents of a deal, such as the strength of Covid-19 testing and tracing requirements. Markets have swung significantly on the rising and falling prospects of a stimulus package in recent weeks, and the two-day deadline will be watched with interest.

FTSE 100 sinks despite Friday rally

London-listed stocks slumped last week; despite a 1.5% rally for the FTSE 100 on Friday the index closed out the week 1.6% lower. International Consolidated Airlines Group was the week’s biggest loser, falling double digits, while Associated British Foods, BP and Barclays also sank by more than 5% over the course of the week.

The FTSE 250 ended the week 1.4% down, dragged lower by hospitality and travel names that are most at risk from new lockdown restrictions with Covid-19 cases surging. Pub chain JD Wetherspoon, Cineworld and easyJet all fell, with the trio part of a dozen or so names that suffered double-digit losses.

There were some bright spots in the FTSE 100 during the week, however, with online takeaway service Just Eat and airliner engine maker Rolls-Royce both enjoying double-digit gains. Just Eat reported surging online orders in a trading update, while investors have responded positively to Rolls-Royce shoring up its finances.

What to watch

IBM: IBM’s post-market close earnings report today will be an interesting one, after the firm announced on October 8 that it plans to spin off its IT outsourcing business. That division accounts for $19BN of the firm’s $59BN in revenue, according to MarketWatch. It leaves behind a hardware, software and services business which the company plans to target at the hybrid-cloud market, where client companies hand off some of their data to a cloud provider to be stored offsite while keeping some data on their own premises. IBM has both the cloud and hardware capabilities to service both parts of a hybrid arrangement but faces stiff competition, and unlike many other cloud providers its share price is down in 2020. Currently, Wall Street analysts favour a hold rating on IBM stock.

Cadence Design Systems: California-based Cadence is an engineering firm that provides structures needed to design circuit boards and chips. Along with many chipmakers, its share price has surged in 2020, and is now up more than 65% year-to-date, boosting its market cap past the $30BN mark. According to Zacks Equity Research, it is an expanding customer base that has driven investor optimism about the stock, along with an uptick in chip design activity and an evolution in semiconductor manufacturing processes. Analysts are expecting a Q3 earnings per share figure of $0.61 when the company reports on Monday, versus $0.54 in Q3 last year.

Reckitt Benckiser: London-listed consumer goods firm Reckitt Benckiser sits behind health and hygiene brands including Dettol and Lysol. Its share price has been boosted by 20% in 2020, while the FTSE 100 has fallen dramatically overall, given the demand for some of its products during the pandemic. The company delivers its latest set of quarterly earnings on Tuesday, where a likely focus will be what surging Covid-19 case numbers in Europe and elsewhere mean for the firm’s sales.

All eyes on the tech giants

The S&P 500's five biggest companies – Apple, Microsoft, Amazon, Alphabet and Facebook – now account for 28% of the index's weighting, and have been responsible for 25% of its earnings, Goldman Sachs said earlier this month. Other major stocks, including Netflix and Tesla, have also delivered huge returns for investors this year.

This week the latter two report third-quarter results, with Netflix on Tuesday, Tesla (and Verizon Communication) on Wednesday, and then other notable name Intel on Thursday, before Apple, Amazon, Alphabet, Microsoft and Facebook report the following week.

While many are now questioning their share prices given the meteoric rise we have already seen, others believe selling now would be an error. Michael Farr, president of Farr, Miller & Washington LLC, told Reuters to rotate out of tech because of big gains and some recent volatility would be “a suckers’ trade”. “Reports of their demise have been greatly exaggerated,” he said of the big tech stocks.

Tickers

S&P 500: -0.8%

Dow Jones IA: -1.43%

Nasdaq Composite: -1.65%

ASX 200: -0.26%

AUD: 0.705

All data, figures & charts are valid as of 20/10/2020. All trading carries risk. Only risk capital you can afford to lose

Today's market update is from eToro's market analyst Adam Vettese.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X